Sichuan Goldstone Asia Pharmaceutical Inc. (SHE:300434)
China flag China · Delayed Price · Currency is CNY
10.45
+0.34 (3.36%)
Sep 14, 2026, 3:04 PM CST

SHE:300434 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
345.7307.32417.29545.9440.31235.43
Short-Term Investments
-40.4715.05101.54--
Trading Asset Securities
135.2860.3414.142.3663.8153.84
Cash & Short-Term Investments
480.97408.14446.44689.79504.12289.27
Cash Growth
-1.00%-8.58%-35.28%36.83%74.27%-40.24%
Accounts Receivable
229.63383.18367.37375.99484.87362.27
Other Receivables
24.9520.7822.4234.1825.3715.36
Receivables
254.58403.96389.79410.17510.24377.63
Inventory
205.68210.57209.75238.16197.37217.7
Prepaid Expenses
0.142.542.543.890.048.32
Other Current Assets
134.3262.5821.4929.5649.353.87
Total Current Assets
1,0761,2881,0701,3721,261946.79
Property, Plant & Equipment
832.75814.98715.12668.57618.06578.31
Long-Term Investments
354.64243.76350.64102.13120.74134.84
Goodwill
109.25109.25109.25109.25176.76176.76
Other Intangible Assets
179.36185.38205.36225.82244.01262.71
Long-Term Deferred Tax Assets
18.6317.3314.5814.839.7310.51
Long-Term Deferred Charges
5.055.695.56.877.569.9
Other Long-Term Assets
554.94561.03584.39602.38621.99648.31
Total Assets
3,1303,2253,0553,1013,0602,768

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
134.19144.6117.08116.5597.387.64
Accrued Expenses
86.1156.57142.64135.91181.34125.4
Short-Term Debt
106.0268.0150110.6210.01-
Current Portion of Long-Term Debt
-7.010.03---
Current Portion of Leases
0.330.981.671.490.050.2
Current Income Taxes Payable
9.87167.0325.9965.5820.32
Current Unearned Revenue
62.99129.9187.72127.14199.89132.32
Other Current Liabilities
35.2567.1185.6883.45123.42154.45
Total Current Liabilities
434.75590.2491.84601.17677.58520.34
Long-Term Debt
--25---
Long-Term Leases
1.38-1.162.710.260.78
Long-Term Unearned Revenue
5.095.354.734.713.383.05
Long-Term Deferred Tax Liabilities
53.0755.4462.1368.527581.39
Other Long-Term Liabilities
0.430.430.460.250.340.56
Total Liabilities
494.73651.42585.32677.37756.56606.12

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
401.74401.74401.74401.74401.74401.74
Additional Paid-In Capital
1,7871,7871,7871,7871,7871,816
Retained Earnings
425.4362.87258.97211.485.2-133.59
Total Common Equity
2,6142,5522,4482,4002,2742,084
Minority Interest
21.1321.8921.5323.6429.1278.26
Shareholders' Equity
2,6362,5742,4702,4242,3032,162
Total Liabilities & Equity
3,1303,2253,0553,1013,0602,768

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
107.737677.86114.8310.310.98
Net Cash (Debt)
373.24332.14368.59574.97493.8288.29
Net Cash Growth
5.80%-9.89%-35.89%16.44%71.29%-39.19%
Net Cash Per Share
0.940.830.921.411.220.74
Filing Date Shares Outstanding
401.74401.74401.74401.74401.74401.74
Total Common Shares Outstanding
401.74401.74401.74401.74401.74401.74
Working Capital
640.92697.6578.18770.42583.48426.45
Book Value Per Share
6.516.356.095.985.665.19
Tangible Book Value
2,3262,2572,1332,0651,8531,644
Tangible Book Value Per Share
5.795.625.315.144.614.09
Buildings
795.63792.51769.63788584.27601.35
Machinery
369.2369.31359.58331.1563.61284.32
Construction In Progress
236.93197.0270.590.41136.9679.8